Safety and Efficacy of NC120 for Improving Lipid Profile: A Double Blind Randomized Controlled Trial
Background: the use of statin to lower blood cholesterol is often associated with bothersome adverse effects such as myopathy and liver dysfunction. NC120 is herbal lipid lowering drug containing red yeast rice (RYR) extract, guggulipid, and chromium picolinate, and expected to have better safety pr...
Saved in:
| Main Authors: | Nafrialdi Nafrialdi, Johannes Hudyono, Frans D Suyatna, Arini Setiawati |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Interna Publishing
2019-05-01
|
| Series: | Acta Medica Indonesiana |
| Subjects: | |
| Online Access: | https://www.actamedindones.org/index.php/ijim/article/view/980 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Efficacy of NC120 for Improving Lipid Profile: A Double Blind Randomized Controlled Trial
by: Nafrialdi Nafrialdi, et al.
Published: (2019-05-01) -
Evaluation of NaTto Red Yeast Rice on Regulating Blood Lipid (ENTRY) Study: A Multicenter, Double‐Placebo, Double‐Blinded, Randomized Controlled Trial in Chinese Adults
by: Shufeng Chen, et al.
Published: (2025-06-01) -
Does EFSA statement on Monacolin content of nutraceutical combinations impair their lipid lowering effect? The LopiGLIK experience
by: Alessia Izzo, et al.
Published: (2024-11-01) -
Beneficial Effects of a Nutraceutical Combination on Lipid Profiles in Children with Moderate and Severe Hypercholesterolemia
by: Anastasia Garoufi, et al.
Published: (2024-12-01) -
Scientific Opinion on additional scientific data related to the safety of monacolins from red yeast rice submitted pursuant to Article 8(4) of Regulation (EC) No 1925/2006
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2025-02-01)